1978
DOI: 10.1136/pgmj.54.633.451
|View full text |Cite
|
Sign up to set email alerts
|

Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM)Supported in part by grant of Deutsche Forschungsgemeinschaft, SFB 30 Kardiologie Düsseldorf.

Abstract: SummaryIn order to find evidence of prognosis and of presymptomatic manifestation of congestive cardiomyopathy (COCM) in fifty-eight patients, the extent of morphological changes of endomyocardial catheter biopsy (EMCB), clinical and haemodynamic data were correlated to the clinical course. In addition, clinical, haemodynamic, angiographic, morphological and His-bundle electrographic studies were performed in patients with left bundle branch block (LBBB), normal left ventricular end-diastolic volume, and norma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
19
1
7

Year Published

1983
1983
2018
2018

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(29 citation statements)
references
References 15 publications
2
19
1
7
Order By: Relevance
“…28 That is, among cardiac hypertrophy, myocyte hypertrophy, and nuclear hypertrophy, only nuclear hypertrophy can distinguish the type of cardiac hypertrophy. At present, there is no morphological marker at the cellular level that distinguishes between normal and impaired systolic function of hypertrophic hearts; 28,29 that is, HCM and DCM cannot be distinguished solely by the histological findings of endomyocardial biopsies. Thus, a high incidence of marked nuclear hypertrophy of myocytes might be a special morphological feature of hypertrophic hearts with ventricular dilatation and systolic dysfunction.…”
Section: Discussionmentioning
confidence: 99%
“…28 That is, among cardiac hypertrophy, myocyte hypertrophy, and nuclear hypertrophy, only nuclear hypertrophy can distinguish the type of cardiac hypertrophy. At present, there is no morphological marker at the cellular level that distinguishes between normal and impaired systolic function of hypertrophic hearts; 28,29 that is, HCM and DCM cannot be distinguished solely by the histological findings of endomyocardial biopsies. Thus, a high incidence of marked nuclear hypertrophy of myocytes might be a special morphological feature of hypertrophic hearts with ventricular dilatation and systolic dysfunction.…”
Section: Discussionmentioning
confidence: 99%
“…was used by the individual pathologists and included acute myocarditis, borderline myocarditis, chronic myocarditis, focal myocarditis, myocarditis, and resolving myocarditis. One pathologist believed that patient 3 had inadequate tissue and three pathologists thought that staining was inadequate in patient 13. Figure 1 is a hematoxylin and eosin-stained slide from patient 7, in whom a diagnosis of definite myocarditis was made by three pathologists; all three agreed that a high lymphocyte count was present.…”
Section: Methodsmentioning
confidence: 99%
“…Rather, in our own study and those of others, bundle-branch block gives the impression of being a marker of a slowly progressing degenerative disease affecting not only the conduction system but also the myocardium. [44][45][46] A slow increase in cumulative mortality over time would then be expected but would be detected only in large populations followed up for a long period of time.…”
Section: Mortalitymentioning
confidence: 99%